| ¡¡¡¡ Peking University People's Hospital
Our Mission
We have a four-fold mission which is to provide the highest quality health care to patients throughout China, especially severe or complicated cases; to educate the next generation of health care rofessionals by being a demonstration centre in medical education; to be a pioneer in scientific research, discovery and patent transfer; and to explore, establish and demonstrate a new model for hospital management and healthcare in China.
Values
We strive to inculcate into all areas of our endeavour the following standard of excellence, namely, "Benevolence & Compassion, Inclusiveness & Diversity, Perceptiveness & Good judgement, and Integrity & Justice".
Patient Care
Throughout its history, the PKUPH's goal of training tomorrow's great physicians, nurses, and scientists has remained steadfast. Above all, it aims to provide the highest quality health care and services for all of its patients. The hospital knows that good care involves more than good medicine. This is why its concern for the patients extends to every part of their stay. It strives to make the patients' experience at PKUPH as pleasant and comfortable as possible. An affiliated hospital of Peking University, Peking University People's Hospital is a nonprofit health care institution that provides an exceptionally caring environment for patients and families, and extends care to patients of any nationality.
About Us
During the past 90 years, PKUPH has vigorously pursued excellence in all that it has done, and today it is nationally renowned for its clinical services, research and teaching excellence, with ten of its Departments, including, Hematology, Cardiology, Ophthalmology, Orthopaedics, Gynaecology, Paediatrics, Urology, Dermatology & Venereology, Nephrology and Rheumatology & Immunology receiving top National honours in their field.
The hospital incorporates four distinguished institutes: Peking University Hematology Institute, Peking University Hepatology Institute, Peking University Arthritis Institute and Peking University Applied Lithotripsy Institute, which have become leaders in their fields.
It has 2,396 staff, including a member of the Chinese Academy of Engineering, Dr Lu Daopei.
In PKUPH more than 23,680 surgical procedures and over 200,000 radiological examinations are performed each year.
It has 1,448 in-patient beds, and admits more than 40,000 inpatients a year. It also receives more than 1,559,000 outpatients, and more than 133,000 emergency cases annually.
PKU Haematology Institute has the largest bone marrow transplant ward in Asia, and is in the top five largest in the world. The annual number of hematopoietic stem cell transplants, including more than one half of HLA mismatched transplants is one third of all performed in China. It has performed more than 1,800 heterogeneic hematopoietic stem cell transplants, and the treatment of acute and chronic leukaemia has recorded over 70% long-term disease-free survival rate.
PKU Hepatology Institute has conducted major national Hepatitis research projects that are integrated with clinical work in liver disease and grouped in the following areas, such as molecular virology, prognosis of HCV infection & optimising treatment for difficult-to-treat Hepatitis C; Immunology and cell biology of hostvirus interrelationships, antiviral therapy for Hepatitis B; immunotherapy of HCC, e.g. vaccine based on tumour antigens; bone marrow stem cell therapy for liver cirrhosis.
PKU Arthritis Institute has completed 5,000 knee joint replacements, 4,000 hip joint replacements, 47 ipsilateral simultaneous total knee and hip replacements and 3 ipsilateral simultaneous total hip, knee and ankle replacements. The research project, "Clinical application and study of artificial knee joint replacement", led by Professor Lu Houshan, got the National Science & Technology Progress Prize in 2007.
The first Chinese equipment for Extra-corporeal Shock Wave Lithotripsy was developed in the PKU Applied Lithotripsy Institute in 1984, and received the National Science & Technology Progress Prize, first class, in 1987.
The Eye Centre has become the largest in north China for vitreo-retinal disease. As a result of its reputation in paediatric ophthalmology, it has become a WHO training centre for childhood blindness prevention. It has achieved rapid growth and currently performs 5,200 major eye surgeries and 2,500 laser procedures a year.
The Heart Centre, through 20 years'constant endeavour, has become the national leader and reached international advanced level in the control of coronary heart disease, clinical cardiac electrophysiology and arrhythmia, hypertension, lipids disorder, as well as thromboembolic disease and research into its causes and epidemiology. It performs more than 600 heart surgeries annually, including more than 250 bypass surgeries.
The Department of Gynaecology and Obstetrics is excellent in the treatment of ovarian cancers, endometrial cancers and cervical cancers. It has accumulated a wealth of experience in the diagnosis and treatment of highrisk pregnancy and pregnancy complications. It has developed various reproductive technologies, such as artificial insemination, in vitro fertilisation, and intracytoplasmic sperm injection.
Teaching Emphasis
PKU People's Hospital has nearly 500 physicians holding faculty appointments as professor or associate professor at Peking University, engaged in undergraduate, postgraduate and continuing medical education. More than 600 students are admitted each year, to study medicine, dentistry and laboratory medicineand more than700 Fellows from hospitals around the country, receive continuing clinical training.
There is an onsite central Education Department, with a clinical technique simulation laboratory where students can diagnose, manage, and learn technical skills on simulated patients. In addition to the eight university courses, there are also three nationallevel courses in Surgery, Anaesthesiology and Ophthalmology.
Research and Publications
PKUPH's leading edge clinical and biomedical research is supported by grants from government agencies and other foundations. It consistently ranks highly among the top teaching hospitals in receiving biomedical research funding from national foundations. This reached almost 148 million RMB in the past two years. PKUPH researchers run more than 100 projects and numerous clinical trials.
Most research experiments are conducted in the hospital's well-equipped central laboratory and have received State Science and Technology Prizes, University Invention Awards, University ScienceTechnology Natural Science Awards, and Chinese Medical Association ScienceTechnology Awards in the past two years.
The hospital published more than 1,230 scientific papers in peerreviewed national and international journals in the past two years.
Outreach
An Integrated Healthcare Delivery Network offers tertiary level care to residents of surrounding communities in Beijing. Through this network, PKUPH provides timely diagnosis & treatment for local patients, especially those with diabetes, cardiovascular diseases and chronic respiratory diseases.
International Relations
More than 2,000 staff members of our faculty, including physicians, nurses and scientists, have engaged in overseas exchange and training. We have established relationships with more than 40 hospitals around the world for academic exchange and collaboration in a variety of fields. About 4,000 visitors from 17 countries and regions have come to PKUPH since 1992.
Did you know that:
Professor Lu Daopei performed the first successful isogeneic bone marrow transplant in Asia, the fourth one in the world, in 1964.
The first successful heterogeneous gene marrow transplant in China was performed in 1981.
Research into"The serum HBV test by spot molecule hybridisation" led by Profesor Tao Qimin, won a National Science & Technology Progress Award in 1985.
Research into "The application of heterogeneous gene marrow transplant in leukaemia"led by Professor Lu Daopei, won a National Science & Technology Progress Award in 1985.
Research into the technology of extracorporeal shock wave lithotripsy got National Science & Technology Progress Prize, first class, in 1987.
Prof. Tao Qimin and her team won the National Science & Technology Progress Award, first class, for the successful invention of the first Hepatitis B vaccine in 1988.
The Ministry of Health approved PKUPH as a "top rank tertiary hospital" in 1994.
Professor Lu Daopei was elected a member of the Chinese Academy of Engineering in 1996.
The Research Project led by Professor Zhu Xueguang, entitled "Strengthen logical thought and application, improve the clinical teaching quality", got a National Teaching Progress Award in 1997.
The first test tube triplets were born in the hospital in 2001.
The first Cord Blood Stem Cell Bank in Beijing started in PKUPH in 2002.
The research project in the area of higher education teaching management led by Professor Wang Shan, received the National Teaching Progress Award, first class, in 2005.
The research project entitled, "The Application and Study of Artificial Knee Joint Replacement"led by Prof. Lu Houshan, won a National Science & Technology Progress Award in 2008.
Professor Shan Wang represented the health care field at the Advisory Symposium on the government report hosted by Premier Wen Jiabao, in 2008.
A large Public Hospital Resource Planning (HRP) System was formally inaugurated in 2008.
History
Peking University People's Hospital (PKUPH) was established to meet the needs of local residents in 1918. It was the first western medical hospital funded and operated by Chinese citizens. The founding president was Dr. Wu Liande, also a founder of the Chinese Medical Association. The hospital was originally named Peking Central Hospital and was but shortly in 1941, a group of renowned physicians and surgeons, including Dr. Zhong Huilan, Dr. Lin Qiaozhi, Dr. Guan Songtao, Dr. Xie Yuanpu, Dr. Meng Jimao, and Dr. Wu Jieping, transferred here from Peking Union Medical College Hospital. They contributed greatly to the improvement of medical care and to teaching a new generation of physicians and nurses.
The hospital has been under the direct supervision of the Chinese Ministry of Health since May 1950, and was renamed Beijing People's Hospital in 1956. It affiliated with the Beijing Medical College in 1958 and has since served as one of its major teaching hospitals. When Beijing Medical University merged with Peking University in 2000, the hospital was renamed Peking University People's Hospital. In 1991, a new campus was built near Xizhimen and, in 1997, a new research and teaching building was opened, followed by the new 20-story inpatient building in 2008. Today, PKUPH functions in an area of over 140,000 sq.m.
|
